• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大麻治疗慢性疼痛:挑战与考量。

Cannabis for Chronic Pain: Challenges and Considerations.

机构信息

Department of Anesthesiology, Pain Mechanisms Laboratory, Wake Forest University School of Medicine, Winston-Salem, North Carolina.

Department of Pharmaceutical and Administrative Sciences, Presbyterian College School of Pharmacy, Clinton, South Carolina.

出版信息

Pharmacotherapy. 2018 Jun;38(6):651-662. doi: 10.1002/phar.2115. Epub 2018 May 16.

DOI:10.1002/phar.2115
PMID:29637590
Abstract

The National Academies of Sciences, Engineering, and Medicine has found substantial evidence that cannabis (plant) is effective for the treatment of chronic pain in adults, and moderate evidence that oromucosal cannabinoids (extracts, especially nabiximols) improve short-term sleep disturbances in chronic pain. The paradoxical superiority of the cannabis plant over cannabinoid molecules represents a challenge for the medical community and the established processes that define modern pharmacy. The expanding and variable legalization of cannabis in multiple states nationwide represents an additional challenge for patients and the medical community because recreational and medicinal cannabis are irresponsibly overlapped. Cannabis designed for recreational use (containing high levels of active ingredients) is increasingly available to patients with chronic pain who do not find relief with current pharmacologic entities, which exposes patients to potential harm. This article analyzes the available scientific evidence to address controversial questions that the current state of cannabis poses for health care professionals and chronic pain patients and sets the basis for a more open discussion about the role of cannabis in modern medicine for pain management. A critical discussion on these points, the legal status of cannabis, and considerations for health care providers is presented.

摘要

美国国家科学院、工程院和医学院发现大量证据表明大麻(植物)可有效治疗成人慢性疼痛,有中等质量证据表明口溶大麻素(提取物,特别是纳比昔莫)可改善慢性疼痛患者的短期睡眠障碍。大麻植物相对于大麻素分子的矛盾优越性,对医学界和定义现代药学的既定流程构成了挑战。全国多个州大麻的不断扩大和多样化合法化,给患者和医学界带来了额外的挑战,因为娱乐性和药用大麻被不负责任地重叠。用于娱乐用途的大麻(含有高水平的活性成分)越来越多地提供给慢性疼痛患者,而这些患者无法从现有药物实体中得到缓解,这使患者面临潜在的伤害。本文分析了现有的科学证据,以解决当前大麻对医疗保健专业人员和慢性疼痛患者带来的有争议的问题,并为更开放地讨论大麻在现代医学疼痛管理中的作用奠定基础。本文还就这些问题、大麻的法律地位以及医疗保健提供者的注意事项进行了批判性讨论。

相似文献

1
Cannabis for Chronic Pain: Challenges and Considerations.大麻治疗慢性疼痛:挑战与考量。
Pharmacotherapy. 2018 Jun;38(6):651-662. doi: 10.1002/phar.2115. Epub 2018 May 16.
2
Cannabis and Cannabinoids for Chronic Pain.大麻和大麻素治疗慢性疼痛。
Curr Rheumatol Rep. 2017 Oct 5;19(11):67. doi: 10.1007/s11926-017-0693-1.
3
Understanding Cannabis-Based Therapeutics in Sports Medicine.理解运动医学中的大麻素疗法。
Sports Health. 2020 Nov/Dec;12(6):540-546. doi: 10.1177/1941738120956604. Epub 2020 Sep 16.
4
Re-branding cannabis: the next generation of chronic pain medicine?重塑大麻品牌:新一代慢性疼痛药物?
Pain Manag. 2015;5(1):13-21. doi: 10.2217/pmt.14.49.
5
Cannabinoids for Treatment of MS Symptoms: State of the Evidence.大麻素治疗多发性硬化症症状:证据现状。
Curr Neurol Neurosci Rep. 2018 Jun 19;18(8):50. doi: 10.1007/s11910-018-0859-x.
6
The madness of medical marijuana and marijuana legalization.医用大麻与大麻合法化的乱象
Ann Clin Psychiatry. 2016 Nov;28(4):229-230.
7
Medical cannabis for the treatment of chronic pain and other disorders: misconceptions and facts.医用大麻治疗慢性疼痛和其他疾病:误解与事实。
Pol Arch Intern Med. 2017 Nov 30;127(11):785-789. doi: 10.20452/pamw.4123. Epub 2017 Oct 25.
8
Medical cannabis: A forward vision for the clinician.医用大麻:临床医生的前瞻性视野。
Eur J Pain. 2018 Mar;22(3):485-491. doi: 10.1002/ejp.1185. Epub 2018 Jan 29.
9
The therapeutic effects of Cannabis and cannabinoids: An update from the National Academies of Sciences, Engineering and Medicine report.大麻和大麻素的治疗效果:来自美国国家科学院、工程院和医学研究所报告的更新。
Eur J Intern Med. 2018 Mar;49:7-11. doi: 10.1016/j.ejim.2018.01.003. Epub 2018 Jan 9.
10
Availability and approval of cannabis-based medicines for chronic pain management and palliative/supportive care in Europe: A survey of the status in the chapters of the European Pain Federation.在欧洲,用于慢性疼痛管理和姑息/支持性治疗的基于大麻的药物的可及性和批准情况:对欧洲疼痛联合会各章节现状的调查。
Eur J Pain. 2018 Mar;22(3):440-454. doi: 10.1002/ejp.1147. Epub 2017 Nov 13.

引用本文的文献

1
Enablers, Barriers and Practical Applications of a Group-Based Pain Self-Management Program for Patients Receiving Medical Cannabis: A Qualitative Study of Patients and Clinicians.医用大麻患者基于小组的疼痛自我管理计划的促进因素、障碍及实际应用:一项针对患者和临床医生的定性研究
Pain Pract. 2025 Jun;25(5):e70052. doi: 10.1111/papr.70052.
2
The Intersection of Rurality, Unmet Treatment Need, and Cannabis Use for Adults with Chronic Pain.农村地区、未满足的治疗需求与慢性疼痛成人使用大麻之间的交叉关系。
Cannabis. 2025 Feb 1;8(1):8-20. doi: 10.26828/cannabis/2024/000233. eCollection 2025.
3
Impact of Healthcare Provider Awareness and Guidance on the Medical Cannabis Experience.
医疗服务提供者的认知与指导对医用大麻体验的影响。
Med Cannabis Cannabinoids. 2025 Feb 18;8(1):47-57. doi: 10.1159/000544125. eCollection 2025 Jan-Dec.
4
Predicting therapy dropout in chronic pain management: a machine learning approach to cannabis treatment.预测慢性疼痛管理中的治疗中断:一种用于大麻治疗的机器学习方法。
Front Artif Intell. 2025 Feb 20;8:1557894. doi: 10.3389/frai.2025.1557894. eCollection 2025.
5
The effects of standardized cannabis products in healthy volunteers and patients: a systematic literature review.标准化大麻产品对健康志愿者和患者的影响:一项系统的文献综述。
Front Pharmacol. 2024 Oct 17;15:1411631. doi: 10.3389/fphar.2024.1411631. eCollection 2024.
6
Fear of COVID-19 Diagnosis and Cannabis Use Patterns Among Adults with Chronic Health Conditions: Results from COVID-19 Cannabis Health Study.患有慢性健康状况的成年人对新冠病毒诊断的恐惧及大麻使用模式:新冠病毒大麻健康研究结果
J Psychoactive Drugs. 2024 Oct 28:1-10. doi: 10.1080/02791072.2024.2421903.
7
Self-Medication Paths: A Descriptive Study Unveiling the Interplay Between Medical and Nonmedical Cannabis in Chronic Pain Management.自我用药途径:揭示医学和非医学大麻在慢性疼痛管理中的相互作用的描述性研究。
Clin J Pain. 2024 Nov 1;40(11):635-645. doi: 10.1097/AJP.0000000000001241.
8
Assessing Dose- and Sex-Dependent Antinociceptive Effects of Cannabidiol and Amitriptyline, Alone and in Combination, and Exploring Mechanism of Action Involving Serotonin 1A Receptors.评估大麻二酚和阿米替林的剂量和性别依赖性镇痛作用,单独使用和联合使用,并探索涉及血清素 1A 受体的作用机制。
J Pharmacol Exp Ther. 2024 Jan 17;388(2):655-669. doi: 10.1124/jpet.123.001855.
9
Self-medication of pain and discomfort with alcohol and other substances by people with HIV infection and substance use disorder: preliminary findings from a secondary analysis.HIV 感染者和物质使用障碍者自行用酒精和其他物质治疗疼痛和不适:二次分析的初步结果。
AIDS Care. 2024 Mar;36(3):414-424. doi: 10.1080/09540121.2023.2275047. Epub 2023 Nov 1.
10
Effects of Terpenes on the Osteoarthritis Cytokine Profile by Modulation of IL-6: Double Face versus Dark Knight?萜类化合物通过调节白细胞介素-6对骨关节炎细胞因子谱的影响:双面还是黑暗骑士?
Biology (Basel). 2023 Jul 28;12(8):1061. doi: 10.3390/biology12081061.